• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用共研磨法提高难溶性药物的溶出行为:制备无溶剂药物-聚合物固体分散体

Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.

作者信息

Yang Caiqin, Xu Xiujuan, Wang Jing, An Zhiqian

机构信息

Pharmaceutical College, Hebei Medical University, Shijiazhuang, China.

出版信息

Chem Pharm Bull (Tokyo). 2012;60(7):837-45. doi: 10.1248/cpb.c12-00034.

DOI:10.1248/cpb.c12-00034
PMID:22790815
Abstract

The solid dispersion (SD) technique is the most effective method for improving the dissolution rate of poorly water-soluble drugs. In the present work, SDs of the Ca2+ channel blocker dipfluzine (DF) with polyvinylpyrrolidone K30 (PVP) and poloxamer 188 (PLXM) were prepared by the powder solid co-grinding method under a solvent-free condition. The properties of all SDs and physical mixtures were investigated by X-ray diffraction, Fourier-transform infrared, differential scanning calorimetry, scanning electron microscopy, dissolution test, and particles size determination. Eutectic compounds were produced between the DF and PLXM matrix during the co-grinding process, whereas glass suspension formed in the SDs with PVP carrier. Hydrogen bond formation was not observed between DF and carriers and DF was microcrystalline state in the PVP and PLXM matrices. The solubility of DF in different concentration of carriers at 25, 31, and 37°C was investigated; the values obtained were used to calculate the thermodynamic parameters of interaction between DF and carriers. The Gibbs free energy (ΔrGθ) values were negative, indicating the spontaneous nature of dispersing DF into the carriers. Moreover, entropy is the drive force when DF disperses into the matrix of PVP, while, enthalpy-driven dispersing encounters in the PLXM carrier. All the SDs of DF/carriers showed a considerably higher dissolution rate than pure DF and the corresponding physical mixtures. The cumulative dissolution rate at 10 min of the SD with a 1 : 3 DF/carrier ratio increased 5.1-fold for PVP and 5.5-fold for PLXM.

摘要

固体分散体(SD)技术是提高难溶性药物溶出速率最有效的方法。在本研究中,采用无溶剂条件下的粉末固体共研磨法制备了钙离子通道阻滞剂双氟嗪(DF)与聚乙烯吡咯烷酮K30(PVP)和泊洛沙姆188(PLXM)的固体分散体。通过X射线衍射、傅里叶变换红外光谱、差示扫描量热法、扫描电子显微镜、溶出度试验和粒度测定等方法对所有固体分散体和物理混合物的性质进行了研究。在共研磨过程中,DF与PLXM基质之间形成了低共熔化合物,而在含有PVP载体的固体分散体中形成了玻璃态悬浮液。未观察到DF与载体之间形成氢键,且DF在PVP和PLXM基质中呈微晶态。研究了DF在25、31和37℃下在不同浓度载体中的溶解度;所得值用于计算DF与载体之间相互作用的热力学参数。吉布斯自由能(ΔrGθ)值为负,表明DF分散到载体中的过程是自发的。此外,当DF分散到PVP基质中时,熵是驱动力,而在PLXM载体中,分散过程是由焓驱动的。所有DF/载体的固体分散体的溶出速率均显著高于纯DF及其相应的物理混合物。DF与载体比例为1∶3的固体分散体在10分钟时的累积溶出率,PVP体系提高了5.1倍,PLXM体系提高了5.5倍。

相似文献

1
Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.采用共研磨法提高难溶性药物的溶出行为:制备无溶剂药物-聚合物固体分散体
Chem Pharm Bull (Tokyo). 2012;60(7):837-45. doi: 10.1248/cpb.c12-00034.
2
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
3
Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.硝苯地平与亲水性载体共研磨混合物的固态及溶解速率表征
Drug Dev Ind Pharm. 2005 Sep;31(8):719-28. doi: 10.1080/03639040500216097.
4
Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.提高难溶性药物的溶解度:吡罗昔康与载体聚合物的低温共研磨
Drug Dev Ind Pharm. 2016;42(3):378-88. doi: 10.3109/03639045.2015.1054400. Epub 2015 Jun 11.
5
To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.提高难溶性药物的溶出速率:盐酸氨基葡萄糖作为固体分散体制剂中的潜在载体。
Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):170-8. doi: 10.1016/j.colsurfb.2009.10.030. Epub 2009 Nov 11.
6
Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.通过传统溶剂蒸发法和超临界法制备的卡马西平在聚乙烯吡咯烷酮K30中的固体分散体。
Int J Pharm. 2004 Mar 19;272(1-2):1-10. doi: 10.1016/j.ijpharm.2003.11.025.
7
Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.使用喷雾干燥机制备的塞来昔布在PVP/异麦芽酮糖醇固体分散体中的异常溶解行为。
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:501-511. doi: 10.1016/j.msec.2016.11.042. Epub 2016 Nov 14.
8
Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.固体分散技术在提高甲氨基阿维菌素苯甲酸盐溶解度和持续释放中的应用。
Molecules. 2019 Nov 26;24(23):4315. doi: 10.3390/molecules24234315.
9
Effect of different carriers on in vitro dissolution behavior and physicochemical characterization of glycyrrhetinic acid solid dispersions.不同载体对甘草次酸固体分散体体外溶出行为及理化性质的影响。
Pak J Pharm Sci. 2022 Nov;35(6):1539-1548.
10
Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.酮洛芬与 PVP K30 和 D-甘露醇固体分散体的理化性质表征及体外溶出度研究。
Saudi Pharm J. 2013 Jan;21(1):77-84. doi: 10.1016/j.jsps.2011.12.007. Epub 2011 Dec 24.

引用本文的文献

1
Clinical effectiveness of orange peel polymethoxy-flavonoids rich fraction as a palatal dressing material compared to Alveogyl: randomized clinical trial.与 Alveogyl 相比,桔皮多甲氧基黄酮丰富部分作为腭部敷料的临床效果:随机临床试验。
Sci Rep. 2024 Feb 6;14(1):3067. doi: 10.1038/s41598-024-53511-4.
2
Control of Crystallization of PBT-PC Blends by Anisotropic SiO and GeO Glass Flakes.通过各向异性的SiO和GeO玻璃薄片控制聚对苯二甲酸丁二醇酯-聚碳酸酯共混物的结晶
Polymers (Basel). 2022 Oct 27;14(21):4555. doi: 10.3390/polym14214555.
3
Preparation, characterizations and anti-pollutant activity of 7,3',4'-trihydroxyisoflavone nanoparticles in particulate matter-induced HaCaT keratinocytes.
7,3',4'-三羟基异黄酮纳米粒子的制备、表征及其在颗粒物诱导 HaCaT 角质形成细胞中的抗污染活性。
Int J Nanomedicine. 2018 Jun 1;13:3279-3293. doi: 10.2147/IJN.S153323. eCollection 2018.
4
Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation.转铁蛋白稳定的紫杉醇纳米晶体制剂的研制与评价。
J Control Release. 2014 Feb 28;176:76-85. doi: 10.1016/j.jconrel.2013.12.018. Epub 2013 Dec 27.
5
Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.丹参酮 IIA 固体分散体与硅纳米粒子的制备、表征及体内评价。
Int J Nanomedicine. 2013;8:2285-93. doi: 10.2147/IJN.S40374. Epub 2013 Jun 25.